![Elizabeth Faust](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 30/06/2026
Elizabeth A. Faust is currently Independent Director at Biomea Fusion, Inc. since 2022 and Principal & Owner at Faust Consulting LLC since 2018.
Former roles include Executive Director-Regional Medical Liaisons at Amgen, Inc., Senior Director-Medical Affairs at Gloucester Pharmaceuticals, Inc. from 2008 to 2010, Vice President-Medical Affairs at Pharmacyclics LLC from 2013 to 2015, Executive Vice President-Medical Affairs at Tricida, Inc. from 2019 to 2020, Vice President-Clinical Research Sciences at Celgene Corp., Vice President-Medical Affairs at Kite Pharma, Inc. from 2016 to 2018, and Vice President-Medical Affairs at Pharmacyclics, Inc. from 2013 to 2015.
Education includes a doctorate from the University of California, Los Angeles, graduate studies at the University of California, Riverside, and undergraduate studies at Auburn University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BIOMEA FUSION INC -.--% | 10/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| BIOMEA FUSION, INC. | Director/Miembro de la Junta | 01/06/2022 |
| Empresas | Cargo | Fin |
|---|---|---|
| TRICIDA, INC. | Director Técnico/Científico/I+D | 01/08/2020 |
| CELGENE | Director Técnico/Científico/I+D | 01/11/2019 |
| KITE PHARMA INC | Director Técnico/Científico/I+D | 01/07/2018 |
| PHARMACYCLICS, INC. | Director Técnico/Científico/I+D | 01/11/2015 |
Pharmacyclics, Inc.
 Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat cancer | Director Técnico/Científico/I+D | 01/11/2015 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Gloucester Pharmaceuticals, Inc.
 Gloucester Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops products for the treatment of cancer patients | Health Technology |
Tricida, Inc.
 Tricida, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical preparation products | Health Technology |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Auburn University
 Auburn University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Riverside
 University of California, Riverside Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kite Pharma, Inc.
 Kite Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biotechnology company which engages in the development of novel cancer immunotherapeutic products | Health Technology |
Biomea Fusion, Inc.
 Biomea Fusion, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which engages in the discovery, development and commercialization of small molecules to treat patients with genetically defined cancers | Health Technology |
Pharmacyclics, Inc.
Pharmacyclics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs to treat cancer | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
